Main > > >NEUROBLASTOMA. *

---

Treat.: DinutuxiMAb.
CA Approval Date : 2018. 11.29.
EU Approval Date : 2015. 08.17.
USA Approval Date: 2015. 03.
(*) Company : United THerapeutics.
TradeMark: Unituxin.
UpDate: 2018. 11.30.




Treat.: DinutuxiMAb Beta. (UK)
Anti-GD2 MAb.
EU Approval Date: 2017. 05.09.
(*) Company; Patents; PR Web-Site &
TradeMark Available on Request.
UpDate: 2018. 11.30.




Treat.: NaxitaMAb gqgk Inj.+GM-CSF
(R/R)
USA Approval Date: 2020. 11.25.
(*) Company; TradeMark; USA Patent APP.
& Web-Site Available on Request.
UpDate: 2021. 03.01.


>NEUROBLASTOMA. *'s products
This section has no products